Navigation Links
Prasco Announces New, Expanded Roles for Key Executives
Date:12/6/2011

CINCINNATI, Dec. 6, 2011 /PRNewswire/ -- Prasco Chairman, Mr. E. Thomas Arington, announced today that Mr. Christopher H. Arington has been promoted to vice chairman and chief executive officer of Prasco.  He also announced the promotion of Mr. David Vucurevich, R.Ph. to president, chief operating officer, Mr. David Furniss as chief financial officer, and Mr. Chris Gilmore vice president, strategic business ventures.

"I am extremely pleased to announce these management changes," said E. Thomas Arington.  "As one of the founders of Prasco, Chris has played a critical role in the development and evolution of the company from day-to-day operations to the larger strategic picture," Arington said.  "Mr. Vucurevich brings extensive experience in the pharmaceutical industry, as well as a 'get it done' management style and a commitment to excellence, which is so appropriate for Prasco at this point in time. As CFO, Mr. David Furniss brings financial acumen and over twenty years of pharmaceutical industry experience.  Mr. Furniss, along with Mr. Chris Gilmore, a former Prasco Authorized Generics Business executive, will play key roles in developing and implementing new business opportunities, including acquisitions," Arington concluded.

"It is an honor to accept the position as Prasco CEO and to join Mr. David Vucurevich, in leading Prasco forward," said Chris Arington, CEO.  "I am extremely pleased with Prasco's existing leadership team and we look forward to expanding Prasco's role in the pharmaceutical industry."

About Prasco Laboratories - Prasco, the Authorized Generics company, is the privately held healthcare company located in Mason, Ohio, that specializes in Authorized Generics. Prasco Authorized Generics provide patients with the identical brand drug experience at a price that competes with generics. Prasco Authorized Generics also simplify interactions between pharmacists and consumers because they are identical to branded drugs. Moreover, Prasco Authorized Generics offer brand pharmaceutical companies a strategic lifecycle management solution.  For more information, visit www.prasco.com.


'/>"/>
SOURCE Prasco Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prasco® Selected as Eli Lilly and Companys Authorized Generics Partner
2. Prasco Named Exclusive U.S. Distributor for Selected Aspen Branded Products
3. Prasco® Launches Authorized Generic with Shionogi Inc.
4. Prasco® Announces Authorized Generic Agreement with Shionogi Inc.
5. Prasco Announces Agreement with Shire for Future Exclusive Distribution and Supply of Authorized Generic for PENTASA®
6. Prasco to Market Authorized Generic of ZEGERID®
7. Prasco and Stiefel Sign Distribution and Supply Agreement for Clobetasol Propionate Foam
8. Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S.
9. CPhI Conferences Announces Details of 5th Annual PharmaSource Conference in Munich
10. Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call
11. AirStrip Technologies Announces Home Health Collaboration With Qualcomm Life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/8/2017)... , June 8, 2017  Less than a ... hit more than 200,000 companies, including hospital networks, in ... heralded as one of the largest online extortion attempts ... the healthcare market, it is imperative that providers understand ... their data from this — and many other very ...
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology:
(Date:6/22/2017)... ... June 23, 2017 , ... ... fight against hunger on June 21, 2017, at the Emeryville Center of Community ... and malnutrition around the world. , Rise Against Hunger (formerly Stop Hunger Now) ...
(Date:6/20/2017)... MA (PRWEB) , ... June 20, 2017 , ... ... and CHRISTUS Health, a Texas-based health system, will present how predictive analytics drive ... annual HFMA ANI meeting in Orlando, June 25-28. , “The traditional approach ...
(Date:6/20/2017)... ... 2017 , ... After months of negotiations, FaceCradle USA is proud to announce the debut of ... , “Introducing our product on QVC is something we all worked hard to achieve for ... more than 90 million homes in the United States,” said FaceCradle USA President Dylan Doherty. ...
(Date:6/20/2017)... ... June 20, 2017 , ... Hayes, Inc., a leading provider ... titled “ 5 Questions to Ask Before Entering the Maze of Genetic Testing ... Evaluation (GTE) team, the book explores the various types of the more than ...
(Date:6/20/2017)... ... June 20, 2017 , ... Kenneth Mayer, MD, has been appointed ... , Dr. Mayer, who joined the JIAS Editorial Board in 2016, has co-authored more ... Director of Fenway Health and Co-Chair of The Fenway Institute, a member ...
Breaking Medicine News(10 mins):